Skip to main content
. 2018 Feb 2;32(7):1561–1566. doi: 10.1038/s41375-018-0017-0

Fig. 3.

Fig. 3

a Genomic HRD-LOH across all myeloma samples with those carrying a mutation in a gene associated with homologous recombination indicated in black (HRmut). b Genomic HRD-LOH by presence of HRmut or wild type (HRwt). Wilcoxon test for difference between groups, p = 0.056. c Genomic HRD-LOH by presence of a BRCA1/2 mutation. Wilcoxon test for difference between groups, p = 0.383. The raw data points and the median and inter-quartile range for each data set are shown. The number and percentage of patients with a mutation identified in each of the genes indicated is shown in the table below the figure